GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Institutional Ownership

Pharma Mar (XMAD:PHM) Institutional Ownership : 8.05% (As of May. 22, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pharma Mar's institutional ownership is 8.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pharma Mar's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pharma Mar's Float Percentage Of Total Shares Outstanding is 0.00%.


Pharma Mar Institutional Ownership Historical Data

The historical data trend for Pharma Mar's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Institutional Ownership Chart

Pharma Mar Historical Data

The historical data trend for Pharma Mar can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 8.57 8.49 8.75 8.61 8.71 8.75 8.85 8.75 8.17 8.05

Pharma Mar Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Pharma Mar (XMAD:PHM) Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (XMAD:PHM) Headlines

From GuruFocus

Q3 2020 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2021 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pultegroup Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Q1 2020 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024